openPR Logo
Press release

Platelet Rich Plasma (PRP) Market Forecast 2017-2021

03-31-2017 04:58 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials. Following types of plate rich plasma (PRP) preparations are currently available in the market:

Leukocyte-poor or pure PRP
Leukocyte PRP
Pure platelet-rich fibrin clot
Leukocyte platelet-rich fibrin clot

Request Free Report Sample@

In spite of non-regulatory approval, PRP has been widely used in sports medicine. Although not clinical proven, it is believed that high concentration of growth factors in PRP boosts bone and soft-tissue repair. Therapeutic applications of PRP include chronic tendon injuries, ligament and muscle injuries, tissue healing in chronic injuries, and arthritis. PRP is also emerging as a popular treatment alternative for hair loss treatment. Various studies have reported success of PRP in restoring hair growth. Currently, PRP therapeutic applications in bone regeneration and sports medicine generate maximum revenue. Veterinary application of PRP is also gaining traction, boosting future market growth. With promising results on Equine, the therapy is now been applied to canine.

North America dominates the global platelet rich plasma market, owing to widespread application in orthopedic, sports medicine, and cosmetic treatment. Device market in the U.S. is highly competitive with over 8 players marketing extraction devices with FDA clearance. Asia is expected to emerge as the most prominent destination for PRP market. Major factors contributing to the market growth are trend for medical tourism, growing popularity of stem cell and regenerative therapy (PRP is perceived as a part of stem cell therapy by customers), and adoption of newer products in cosmetic treatment. Lack of skilled physicians and complications arising from unapproved use of PRP therapies are major threats to the platelet rich plasma market globally.

Request For TOC@

Currently numerous brand of PRP extraction devices with FDA clearance are available in the market. These devices vary greatly in terms of process time, yield and cost. DePuy Synthes PEAK Platelet Rich Plasma System and Dr PRP Rmedica are claimed to isolates over 90% of the platelets and growth factors. The preparation is intended for use with autograft and/or allograft bone prior to application in bone recovery. PEAK Platelet Rich Plasma System had received FDA clearance in 2014. Leading players in the platelet rich plasma market include Harvest Technologies, Biomet, Arthrex, Arteriocyte Medical System, Dr. PRP America, EmCyte, Regen Lab, Exactech and Cesca Therapeutics.

NOTE: This report is currently under research and will be made available to clients on request.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
Office No. 14,
Hermes Kunj, Mangaldas Road,
Pune, 411001
Phone: +91-02041210872

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Platelet Rich Plasma (PRP) Market Forecast 2017-2021 here

News-ID: 488822 • Views:

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-2021
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2021
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for PRP

Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth. The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Global Platelet Rich Plasma (PRP) Industry
Global Platelet Rich Plasma (PRP) Industry Global PRP market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Harvest Technologies DePuy Synthes Stryker Zimmer Biomet Arthrex Exactech Emcyte Corporation Arteriocyte Adilyfe Try Sample Report @ Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of PRP in
Competitive Landscape for PRP Market Key Trends 2024
Global Platelet Rich Plasma (PRP) Market: Snapshot Of late, the global market for platelet rich plasma (PRP) has been witnessing a remarkable rise in its valuation. The upswing in the incidence of orthopedic diseases, propelled by the increasing cases of sports injuries, and the growing prevalence of cardiothoracic and neurological disorders has emerged as the main factor behind this tremendous growth of this market. In addition to this, the surge in cosmetic
Driving eligibility stays after multispot PRP laser treatment
Multispot Panretinal Photocoagulation Spares Visual Fields Required For Driving Eligibility Valon Lasers is pleased to report that Valon Multispot Laser panretinal photocoagulation (PRP) in proliferative diabetic retinopathy spares visual fields required for driving eligibility according to a study from University College London Institute of Ophthalmology, U.K. Recently published study by Professor Michel Michaelides et al. assessed the effect of Multispot laser PRP on retinal sensitivity and visual fields required for driving